American Heart Journal
Volume 144, Issue 5 , Pages 753-759 , November 2002

Carotid artery intimal-medial thickness: Indicator of atherosclerotic burden and response to risk factor modification

Received 5 June 2001 ,Accepted 12 March 2002.

References 

  1. Crouse JRD, Thompson CJ. An evaluation of methods for imaging and quantifying coronary and carotid lumen stenosis and atherosclerosis. Circulation. 1993;8:II17–II33
  2. Pignoli P, Tremoli E, Poli A, et al.  Intimal plus medial thickness of the arterial wall: a direct measurement with ultrasound imaging. Circulation. 1986;74:1399–1406
  3. Pauciullo P, Iannuzzi A, Sartorio R, et al.  Increased intima-media thickness of the common carotid artery in hypercholesterolemic children. Arterioscler Thromb. 1994;14:1075–1079
  4. Heiss G, Sharrett AR, Barnes R, et al.  Carotid atherosclerosis measured by B-mode ultrasound in populations: associations with cardiovascular risk factors in the ARIC study. Am J Epidemiol. 1991;134:250–256
  5. Salonen R, Salonen JT. Progression of carotid atherosclerosis and its determinants: a population-based ultrasonography study. Atherosclerosis. 1990;81:33–40
  6. Dobs AS, Nieto FJ, Szklo M, et al.  Risk factors for popliteal and carotid wall thicknesses in the ARIC Study. Am J Epidemiol. 1999;150:1055–1067
  7. Chambless LE, Shahar E, Sharrett AR, et al.  Association of transient ischemic attack/stroke symptoms assessed by standardized questionnaire and algorithm with cerebrovascular risk factors and carotid artery wall thickness. Am J Epidemiol. 1996;144:857–866
  8. Blankenhorn DH, Hodis HN. George Lyman Duff Memorial Lecture: arterial imaging and atherosclerosis reversal. Arterioscler Thromb. 1994;14:177–192
  9. Bots ML, Hoes AW, Koudstaal PJ, et al.  Common carotid intima-media thickness and risk of stroke and myocardial infarction: the Rotterdam Study. Circulation. 1997;96:1432–1437
  10. Visona A, Pesavento R, Lusiani L, et al.  Intimal medial thickening of common carotid artery as indicator of coronary artery disease. Angiology. 1996;47:61–66
  11. del Sol AI, Moons KG, Hollander M, et al.  Is carotid intima-media thickness useful in cardiovascular disease risk assessment? the Rotterdam Study. Stroke. 2001;32:1532–1538
  12. Probstfield JL, Byington RP, Egan DA, et al.  Methodological issues facing studies of atherosclerotic change. Circulation. 1993;87:II74–II81
  13. Chambless LE, Zhong MM, Arnett D, et al.  Variability in B-mode ultrasound measurements in the ARIC study. Ultrasound Med Biol. 1996;22:545–554
  14. Glagov S, Zarins C. Quantitative atherosclerosis: problems of definition. In:  Bond M,  Insull W,  Glagov S, et al. editor. Clinical diagnosis of atherosclerosis: quantitative methods of evaluation. New York: Springer-Verlag; 1983;p. 11–15
  15. Hodis HN, Mack WJ, LaBree L, et al.  The role of carotid arterial intima-media thickness in predicting clinical coronary events. Ann Intern Med. 1998;128:262–269
  16. Craven TE, Ryu JE, Espeland MA, et al.  Evaluation of the associations between carotid artery atherosclerosis and coronary artery stenosis: a case-control study. Circulation. 1990;82:1230–1242
  17. Lekakis JP, Papamichael CM, Cimponeriu AT, et al.  Atherosclerotic changes of extracoronary arteries are associated with the extent of coronary atherosclerosis. Am J Cardiol. 2000;85:949–952
  18. Balbarini A, Buttitta F, Limbruno U, et al.  Usefulness of carotid intima-media thickness measurement and peripheral B-mode ultrasound scan in the clinical screening of patients with coronary artery disease. Angiology. 2000;51:269–279
  19. Medical diagnostic ultrasound instrumentation and clinical interpretation: report of the ultrasonography task force. JAMA. 1991;265:1155–1159 Council on Scientific Affairs
  20. Salonen JT, Salonen R. Ultrasound B-mode imaging in observational studies of atherosclerotic progression. Circulation. 1993;87:II56–II65
  21. Aminbakhsh A, Mancini GB. Carotid intima-media thickness measurements: what defines an abnormality? a systematic review. Clin Invest Med. 1999;22:149–157
  22. Stensland-Bugge E, Bonaa KH, Joakimsen O. Reproducibility of ultrasonographically determined intima-media thickness is dependent on arterial wall thickness. The Tromso study. Stroke. 1997;28:1972–1980
  23. Sidhu PS, Desai SR. A simple and reproducible method for assessing intimal-medial thickness of the common carotid artery. Br J Radiol. 1997;70:85–89
  24. Pitt B, Byington RP, Furberg CD, et al.  Effect of amlodipine on the progression of atherosclerosis and the occurrence of clinical events. Circulation. 2000;102:1503–1510 PREVENT Investigators
  25. Anand SS, Yusuf S, Vuksan V, et al.  Differences in risk factors, atherosclerosis, and cardiovascular disease between ethnic groups in Canada: SHARE. Lancet. 2000;356:279–284
  26. Lonn E, Yusuf S, Dzavik V, et al.  Effects of ramipril and vitamin E on atherosclerosis: the study to evaluate carotid ultrasound changes in patients treated with ramipril and vitamin E (SECURE). Circulation. 2001;103:919–925
  27. Espeland MA, Craven TE, Riley WA, et al.  Reliability of longitudinal ultrasonographic measurements of carotid intimal-medial thicknesses. Asymptomatic Carotid Artery Progression Study Research Group Stroke. 1996;27:480–485
  28. O'Leary DH, Polak JF, Kronmal RA, et al.  Distribution and correlates of sonographically detected carotid artery disease in the Cardiovascular Health Study. Stroke. 1992;23:1752–1760
  29. Mannami T, Konishi M, Baba S, et al.  Prevalence of asymptomatic carotid atherosclerotic lesions detected by high-resolution ultrasonography and its relation to cardiovascular risk factors in the general population of a Japanese city: the Suita study. Stroke. 1997;28:518–525
  30. Salonen JT, Salonen R. Ultrasonographically assessed carotid morphology and the risk of coronary heart disease. Arterioscler Thromb. 1991;11:1245–1249
  31. Chambless LE, Heiss G, Folsom AR, et al.  Association of coronary heart disease incidence with carotid arterial wall thickness and major risk factors: ARIC Study, 1987-1993. Am J Epidemiol. 1997;146:483–494
  32. O'Leary DH, Polak JF, Kronmal RA, et al.  Carotid-artery intima and media thickness as a risk factor for myocardial infarction and stroke in older adults. Cardiovascular Health Study Collaborative Research Group N Engl J Med. 1999;340:14–22
  33. Karason K, Wikstrand J, Sjostrom L, et al.  Weight loss and progression of early atherosclerosis in the carotid artery: a four-year controlled study of obese subjects. Int J Obes Relat Metab Disord. 1999;23:948–956
  34. Markus RA, Mack WJ, Azen SP, et al.  Influence of lifestyle modification on atherosclerotic progression determined by ultrasonographic change in the common carotid intima- media thickness. Am J Clin Nutr. 1997;65:1000–1004
  35. Probstfield JL, Margitic SE, Byington RP, et al.  Results of the primary outcome measure and clinical events from the Asymptomatic Carotid Artery Progression Study. Am J Cardiol. 1995;76:47C–53C
  36. Byington RP, Furberg CD, Crouse JR, et al.  Pravastatin, Lipids, and Atherosclerosis in the Carotid Arteries (PLAC-II). Am J Cardiol. 1995;76:54C–59C
  37. MacMahon S, Sharpe N, Gamble G, et al.  Effects of lowering average of below-average cholesterol levels on the progression of carotid atherosclerosis: results of the LIPID Atherosclerosis Substudy. Circulation. 1998;97:1784–1790
  38. Hodis HN, Mack WJ, LaBree L, et al.  Reduction in carotid arterial wall thickness using lovastatin and dietary therapy: a randomized controlled clinical trial. Ann Intern Med. 1996;124:548–556
  39. Byington R. Review of carotid ultrasound trials of lipid-lowering agents. Q J Cardiol. 1999;4:4A–13A
  40. Shinomiya M, Shirai K, Saito Y, et al.  Inhibition of intimal thickening of the carotid artery of rabbits and of outgrowth of explants of aorta by probucol. Atherosclerosis. 1992;97:143–148
  41. Baldassarre D, Franceschini G, Peruzzotti G, et al.  Clinical evaluation of probucol in hypercholesteremia: individual lipoprotein responses and inhibitory effect on carotid atherosclerosis progression. J Cardiovasc Pharmacol. 1997;30:784–789
  42. Borhani NO, Mercuri M, Borhani PA, et al.  Final outcome results of MIDAS. A randomized controlled trial. JAMA. 1996;276:785–791
  43. Zanchetti A, Rosei EA, Dal Palu C, et al.  The VHAS: results of long-term randomized treatment with either verapamil or chlorthalidone on carotid intima-media thickness. J Hypertens. 1998;16:1667–1676
  44. Yanez ND, Kronmal RA, Shemanski LR. The effects of measurement error in response variables and tests of association of explanatory variables in change models. Stat Med. 1998;17:2597–2606
  45. Koshiyama H, Tanaka S, Minamikawa J. Effect of the calcium channel blocker amlodipine on the intimal-medial thickness of carotid arterial wall in type 2 diabetes. J Cardiovasc Pharmacol. 1999;33:894–896
  46. MacMahon S, Sharpe N, Gamble G, et al.  Randomized, placebo-controlled trial of the angiotensin-converting enzyme inhibitor, ramipril, in patients with coronary or other occlusive arterial disease. J Am Coll Cardiol. 2000;36:438–443
  47. Minamikawa J, Tanaka S, Yamauchi M, et al.  Potent inhibitory effect of troglitazone on carotid arterial wall thickness in type 2 diabetes. J Clin Endocrinol Metab. 1998;83:1818–1820
  48. Blankenhorn DH, Selzer RH, Crawford DW, et al.  Beneficial effects of colestipol-niacin therapy on the common carotid artery: two- and four-year reduction of intima-media thickness measured by ultrasound. Circulation. 1993;88:20–28
  49. Furberg CD, Adams HP, Applegate WB, et al.  Effect of lovastatin on early carotid atherosclerosis and cardiovascular events. Asymptomatic Carotid Artery Progression Study (ACAPS) Research Group Circulation. 1994;90:1679–1687
  50. Denarie N, Simon A, Chironi G, et al.  Difference in carotid artery wall structure between Swedish and French men at low and high coronary risk. Stroke. 2001;32:1775–1779
  51. Greenland P, Abrams J, Aurigemma GP, et al.  Beyond secondary prevention: identifying the high-risk patient for primary prevention: noninvasive tests of atherosclerotic burden: Writing Group III. Circulation. 2000;101:E16–E22

 Reprint requests: Jay S. Yadav, MD, Cleveland Clinic Foundation, Department of Cardiology, F25, 9500 Euclid Ave, Cleveland, OH 44195.

☆☆ E-mail: yadavj@ccf.org

PII: S0002-8703(02)00182-5

doi: 10.1067/mhj.2002.124865

American Heart Journal
Volume 144, Issue 5 , Pages 753-759 , November 2002